NASDAQ:AIMT - Aimmune Therapeutics Price Target & Analyst Ratings

+0.25 (+1.38 %)
(As of 07/22/2019 07:36 AM ET)
Today's Range
Now: $18.34
50-Day Range
MA: $19.97
52-Week Range
Now: $18.34
Volume493,691 shs
Average Volume628,066 shs
Market Capitalization$1.15 billion
P/E RatioN/A
Dividend YieldN/A

Analyst Ratings

Aimmune Therapeutics (NASDAQ:AIMT) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
6 Wall Street analysts have issued ratings and price targets for Aimmune Therapeutics in the last 12 months. Their average twelve-month price target is $44.6667, suggesting that the stock has a possible upside of 143.55%. The high price target for AIMT is $79.00 and the low price target for AIMT is $30.00. There are currently 2 hold ratings and 4 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.672.672.712.78
Ratings Breakdown: 0 Sell Rating(s)
2 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $44.6667$50.50$49.0014$50.5567
Price Target Upside: 143.55% upside150.74% upside119.84% upside113.05% upside

Aimmune Therapeutics (NASDAQ:AIMT) Consensus Price Target History

Aimmune Therapeutics (NASDAQ:AIMT) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/12/2019Roth CapitalInitiated CoverageBuy ➝ Buy$45.00LowView Rating Details
7/11/2019WedbushSet Price TargetBuy$79.00MediumView Rating Details
5/21/2019Credit Suisse GroupInitiated CoverageOutperform$36.00 ➝ $30.00HighView Rating Details
5/9/2019Cantor FitzgeraldReiterated RatingBuy$45.00MediumView Rating Details
12/20/2018Goldman Sachs GroupSet Price TargetHold$36.00HighView Rating Details
11/11/2018Stifel NicolausSet Price TargetHold$33.00HighView Rating Details
5/18/2018Piper Jaffray CompaniesInitiated CoverageOverweight$60.00 ➝ $30.01HighView Rating Details
2/27/2018Royal Bank of CanadaBoost Price TargetOutperform$62.00MediumView Rating Details
2/20/2018Deutsche BankSet Price TargetBuy$30.00HighView Rating Details
12/20/2017Robert W. BairdInitiated CoverageOutperform ➝ Outperform$64.00MediumView Rating Details
(Data available from 7/22/2017 forward)
This page was last updated on 7/22/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel